Summit Rock Advisors, LP
- SEC CIK
- 0001540951
- Latest filing
- Aug 4, 2026
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Oct 26, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 5
- +1 vs. Q2 2021
- Portfolio value
- $168.6M
- −$83.8M (−33.2%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| iShares Tr464287630 | RUS 2000 VAL ETF | 414,052 | $66.3M | 39.4% | −301,112−42.1% | Reduced | – |
| iShares Core S&P US Value ETF464287663 | ETF | 740,195 | $52.5M | 31.1% | 00.0% | Unchanged | – |
| Vanguard Morningstar Value ETF922908744 | ETF | 348,077 | $47.1M | 28.0% | −229,314−39.7% | Reduced | – |
| CLOVClover Health Investments, Corp. | COM CL A | 210,639 | $1.56M | 0.9% | +210,639 | New | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 34,100 | $1.09M | 0.6% | 00.0% | Unchanged | History |